SEC Form 4 · accession 0001209191-17-059148
bluebird bio, Inc. · BLUE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Nick Leschly
Officer — President and CEO · Director
Period of report
Nov 1, 2017
Accepted (ET)
Nov 3, 2017 · 4:08 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001293971
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Nov 1, 2017 | M | 2,127 | $5.5004 | A | 257,486 | D | |
| Common StockF2 | Nov 1, 2017 | S | 2,127 | $145.1713 | D | 255,359 | D | |
| Common Stock | holding | — | — | — | 17,186 | I | Nick Leschly 2001 Trust |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F3 | $5.5004 | Nov 1, 2017 | M | 2,127 | D | — | Jan 16, 2023 | Common Stock | 2,127 | 241,228 | D |
Explanation of responses
- F1The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 22, 2016.
- F2The range of prices for the transaction reported on this line was $145.00 to $145.30. The average weighted price was $145.1713. The reporting person will provide, upon request by the SEC, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F3This option to purchase shares of our common stock was granted on January 16, 2013 with performance-based vesting criteria that were met as of May 1, 2013. The shares underlying these options vested as follows: 25% vested on May 1, 2014, with the remainder of the shares vesting in equal monthly installments over the following three years.